Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Tobacco Smoking 1Stomach Neoplasms 1Smoking 1Pain 1Neurotoxicity Syndromes 1Neoplasms 1Lung Neoplasms 1Cigarette Smoking 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Letrozole 221Capecitabine 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 132Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Cycloserine × Clear all
NCT00903591 2026-06-03

Study of Radiation Exposure and Bilateral Breast Cancer

Memorial Sloan Kettering Cancer Center

Active not recruiting
1,699 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT00301080 2013-12-02

D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain

Northwestern University

Phase 3 Terminated
7 enrolled 3 charts
Breast

Breast Neoplasms, Pain, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡